+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Turkey Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

  • PDF Icon

    Report

  • 46 Pages
  • October 2023
  • Region: Turkey
  • MarketLine
  • ID: 5782109
Description Jump to:
Pharmaceuticals in Turkey industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Turkish pharmaceuticals market had total revenues of $7.6 billion in 2022, representing a compound annual growth rate (CAGR) of 1.7% between 2017 and 2022.
  • 0
  • The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the Turkish Statistical Institute, total health expenditure increased by 41.6% in 2021 compared to the previous year and reached TRY353.9 billion ($39.7 billion).

Scope

  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Turkey
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Turkey
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Turkey pharmaceuticals market with five year forecasts by both value and volume

Reasons to Buy

  • What was the size of the Turkey pharmaceuticals market by value in 2022?
  • What will be the size of the Turkey pharmaceuticals market in 2027?
  • What factors are affecting the strength of competition in the Turkey pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Turkey's pharmaceuticals market?

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent partnerships?
8 Company Profiles
8.1. Novartis AG
8.2. Sanofi SA
8.3. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
8.4. Pfizer Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher
List of Tables
Table 1: Turkey pharmaceuticals market value: $ billion, 2017-22
Table 2: Turkey pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Turkey pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Novartis AG: key facts
Table 5: Novartis AG: Annual Financial Ratios
Table 6: Novartis AG: Key Employees
Table 7: Novartis AG: Key Employees Continued
Table 8: Sanofi SA: key facts
Table 9: Sanofi SA: Annual Financial Ratios
Table 10: Sanofi SA: Key Employees
Table 11: Sanofi SA: Key Employees Continued
Table 12: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: key facts
Table 13: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
Table 14: Pfizer Inc.: key facts
Table 15: Pfizer Inc.: Annual Financial Ratios
Table 16: Pfizer Inc.: Key Employees
Table 17: Pfizer Inc.: Key Employees Continued
Table 18: Turkey size of population (million), 2018-22
Table 19: Turkey gdp (constant 2005 prices, $ billion), 2018-22
Table 20: Turkey gdp (current prices, $ billion), 2018-22
Table 21: Turkey inflation, 2018-22
Table 22: Turkey consumer price index (absolute), 2018-22
Table 23: Turkey exchange rate, 2018-22
List of Figures
Figure 1: Turkey pharmaceuticals market value: $ billion, 2017-22
Figure 2: Turkey pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Turkey pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Turkey, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Turkey, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Turkey, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Turkey, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Turkey, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Turkey, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Novartis AG
  • Sanofi SA
  • Abdi Ibrahim Ilac Sanayi ve Ticaret AS
  • Pfizer Inc.

Related Topics

Related Reports

Turkey Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Turkey Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 80 Pages
  • Turkey
From
Middle East & Africa Pharmaceuticals Market-Segmented By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application, By Distribution Channel, By Country, By Company (2022) - Product Image

Middle East & Africa Pharmaceuticals Market-Segmented By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application, By Distribution Channel, By Country, By Company (2022)

  • Report
  • 88 Pages
  • Africa, Middle East
From
Pharmerging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Pharmerging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 149 Pages
  • Global
From
Global Specialty Pharmaceuticals Market by Type (CNS, Infectious Diseases, Oncology), Product (Oral Pharmaceuticals, Parenteral Pharmaceuticals, Transdermal Pharmaceuticals), Distribution Channel - Forecast 2024-2030 - Product Image

Global Specialty Pharmaceuticals Market by Type (CNS, Infectious Diseases, Oncology), Product (Oral Pharmaceuticals, Parenteral Pharmaceuticals, Transdermal Pharmaceuticals), Distribution Channel - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Rare Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Rare Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 113 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.